Neurology of the newborn, 2008. ,
Epileptogenesis in the immature brain: emerging mechanisms, Nat Rev Neurol, vol.5, pp.380-91, 2009. ,
Maturation aspects of epilepsy mechanisms and consequences for the immature brain, Epilepsia, vol.42, issue.5, pp.577-85, 2001. ,
Epidemiolgy and aetiology of neonatal seizures, Semin Fetal Neonatal Med, vol.18, issue.4, pp.185-91, 2013. ,
A population-based study of neonatal seizures in Fayette County, Kentucky. Neurology, vol.45, pp.724-756, 1995. ,
The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study, J Pediatr, vol.134, pp.71-76, 1999. ,
, Am J Epidemiol, vol.150, pp.763-772, 1992.
Neonatal seizures-part 2 : aetiology of acute symptomatic seizures, treatments and the neonatal epilepsy syndromes, Arch Dis Child Educ Pract Ed, vol.100, pp.226-258, 2015. ,
Epilepsy after neonatal seizures : literature review, Eur J Paediatr Neurol, vol.19, issue.1, pp.6-14, 2015. ,
Risk factors and scoring system as a prognostic tool epilepsy after neonatal seizures, Pediatr Neurol, vol.50, issue.1, pp.77-84, 2014. ,
, World Health Organization. Guidelines on neonatal seizures. Geneva: WHO, 2011.
Neonatal seizures: treatment practices among term and preterm, Pediatr Neurol, vol.46, pp.111-116, 2012. ,
Differing attitudes toward phenobarbital use in the neonatal period among neonatologists and child neurologists in Sweden, Eur J Paediatr Neurol, vol.17, pp.55-63, 2013. ,
Antiepileptic drugs and apoptotic neurodegeneration in the developing brain, Proc Natl Acad Sci U S A, vol.99, pp.15089-94, 2002. ,
Phenobarbital for febrile seizures effects on intelligence and on seizure recurrence, N Engl J Med, vol.322, pp.364-373, 1990. ,
Neonatal seizures : the beginning and interruption of the treatment, Rev Neurol, vol.25, issue.141, pp.706-714, 1997. ,
Criteria for discontinuing neonatal seizure therapy: a long-term appraisal, Brain and Development, vol.5, pp.541-549, 1983. ,
Contemporary profile of seizures in neonates : a prospective cohort study, J Pediatr, vol.174, pp.98-103, 2016. ,
Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures, Arch Dis Child Fetal Neonatal Ed, vol.93, pp.187-91, 2008. ,
Epilepstic seizures, epilepsy and epieptic syndromes in newborns : a nosological approach of 94 new cases by the 2001 proposed diagnostic scheme for people with epileptic seizures and epilepsy, Seizure, vol.14, issue.5, pp.304-315, 2005. ,
Neonatal seizures : Muticenter variability in current treatment Pratices, Pediatr Neurol, vol.37, pp.85-90, 2007. ,
Hachon LeCamus C. adverse effects of treatment with Valproic acid during the neonatal period, Neuropediatrics, 2018. ,
Treatment of neonatal seizures with carbamazepine, J Child Neurol, vol.11, pp.378-82, 1996. ,
Carbamazepine in phenobarbital-non responders: experience with ten preterm infants, Eur J Pediatr, vol.160, pp.444-451, 2001. ,
Prospective open-label, single-arm, multicenter, safety, tolerability, and pharmacokinetic studies of intravenous levetiracetam in children with epilepsy, J Child Neurol, vol.28, issue.11, pp.1423-1432, 2013. ,
Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures, Neurology, vol.66, pp.1654-60, 2006. ,
Use of intravenous levetiracetam for management of acute seizures in neonates, Pediatr Neurol, vol.44, pp.265-274, 2011. ,
Intravenous levetiracetam for treatment of neonatal seizures, J Clin Neurosci, vol.20, pp.1165-1172, 2013. ,
Levetiracetam for treatment of neonatal seizures, J Child Neurol, vol.26, pp.465-70, 2011. ,
Levetiracetam: safety and efficacy in neonatal seizures, Eur J Paediatr Neurol, vol.15, issue.1, pp.1-7, 2011. ,
Valproic acid in neonatal status convulsivus, Brain Dev, vol.8, issue.3, pp.278-820, 1986. ,
Intravenous valproate dosing in neonates, J Child Neurol, vol.15, issue.12, pp.827-836, 2000. ,
Valproic acid efficacy, toxicity, and pharmacokinetics in neonates with intractable seizures, Neurology, vol.38, issue.3, pp.467-71, 1988. ,
Pharmacokinetic study of valproic acid in a neonate, Pediatr Pharmacol, vol.2, issue.4, pp.317-338, 1982. ,
Neuropathology of vigabatrin, Br J Clin Pharmac, vol.27, pp.43-48, 1989. ,
A study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Listerhooded rats, Toxicol Pathol, vol.15, pp.143-151, 1987. ,
Severe persistent visual field constriction associated with vigabatrin, BMJ, vol.314, p.180, 1997. ,
Prevalence of visual fiels loss following exposure to vigabatrin therapy: a systematic review, Epilepsia, vol.51, issue.12, pp.2123-2154, 2010. ,
Protocole de surveillance ophtalmologique des patients traites par antipaludeens de synthese ou par vigabatrin au long cours, Journal francais d'ophtalmologie, vol.32, pp.83-88, 2009. ,
Vigabatrin monotherapy in resistant neonatal seizures, Seizure, vol.4, pp.57-66, 1995. ,
Pharmacokinetics of the inidvidual enantiomers of vigabatrin in neonates with uncontrolled seizures, Br J Clin Pharmacol, vol.42, pp.779-81, 1996. ,
Early effective treatment of KCNQ2 encephalopathy, Epilepsia, vol.56, issue.5, pp.685-91, 2015. ,
Rapid and safe response to low-dose carbamazepine in neonatal epilepsy, Epilepsia, vol.57, issue.12, pp.2019-2049, 2016. ,
Efficacy of sodium channel blockers in SCN2A early infantile epileptic encephalopathy. Brain and Development, vol.39, pp.345-353, 2017. ,
Prise en charge thérapeutique des convulsions associées à l'accident vasculaire cérébral du nouveau-né et perspectives de neuroprotection à la phase aiguë, Arch Pediatr, vol.24, issue.9, pp.9-46, 2017. ,